4//SEC Filing
Goldberg Jeff Marc 4
Accession 0001209191-22-059262
CIK 0001636282other
Filed
Nov 30, 7:00 PM ET
Accepted
Dec 1, 8:47 PM ET
Size
5.6 KB
Accession
0001209191-22-059262
Insider Transaction Report
Form 4
Goldberg Jeff Marc
DirectorPresident and CEO
Transactions
- Award
Employee Stock Option (right to buy)
2022-11-29+1,884,838→ 1,884,838 totalExercise: $1.22Exp: 2032-11-28→ Common Stock (1,884,838 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable as to 1/4 of the total award on November 29, 2023, and an additional 1/48 of the award will vest monthly thereafter until the option is 100% vested on November 29, 2026, subject to the Reporting Person's provision of service to the Issuer on each vesting date.
Documents
Issuer
Aeglea BioTherapeutics, Inc.
CIK 0001636282
Entity typeother
Related Parties
1- filerCIK 0001703061
Filing Metadata
- Form type
- 4
- Filed
- Nov 30, 7:00 PM ET
- Accepted
- Dec 1, 8:47 PM ET
- Size
- 5.6 KB